- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Ovalbumin.
Displaying page 1 of 1.
EudraCT Number: 2012-005480-28 | Sponsor Protocol Number: IJG-FER-2012 | Start Date*: 2013-05-21 |
Sponsor Name:Institut d?Investigació en Atenció Primaria IDIAP Jordi Gol | ||
Full Title: Effectiveness of adaptation of the dose of iron supplementation in pregnancy on maternal-child health. Randomized clinical trial (ECLIPSES) | ||
Medical condition: Pregnant women, less than 12 week of gestations,without anemia (Hb <110 d / dL) in the pre-analytical at 12 weeks | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001510-40 | Sponsor Protocol Number: TM-ME3710/304 | Start Date*: 2005-07-12 |
Sponsor Name:TEDEC MEIJI FARMA, S.A. | ||
Full Title: Prospective randomized study to assess the efficacy and tolerability of ferrimannitol ovoalbumin compared to ferrous sulphate in the treatment of iron deficiency anaemia | ||
Medical condition: Iron deficiency anaemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002031-26 | Sponsor Protocol Number: RHMCHI065 | Start Date*: 2013-06-25 | |||||||||||
Sponsor Name:University Hospitals Southampton NHS Foundation Trust | |||||||||||||
Full Title: Safety of Nasal Influenza Immunisation in Egg Allergic Children - The SNIFFLE study | |||||||||||||
Medical condition: Children aged 24 months to (and including) 17 years with IgE-mediated food allergy to egg protein | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001295-65 | Sponsor Protocol Number: TXC-CD-002-2011 | Start Date*: 2014-11-28 | |||||||||||
Sponsor Name:TxCell | |||||||||||||
Full Title: A phase IIb, multicentre, randomised, double-blinded (DB), placebo-controlled, single-dose and parallel-group study to evaluate the efficacy and the safety of Ovasave (ovalbumin-specific autologous... | |||||||||||||
Medical condition: Moderately to severely active Crohn's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) AT (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001923-11 | Sponsor Protocol Number: Nef-202 | Start Date*: 2012-10-17 | |||||||||||
Sponsor Name:Pharmalink AB | |||||||||||||
Full Title: A Multicentre, Interventional Treatment, Randomised, Double-Blind, Single Group Assignment, Placebo Controlled Study to Evaluate the Efficacy and Safety of Two Different Doses of Nefecon® in Primar... | |||||||||||||
Medical condition: Primary IgA nephropathy patients at risk of developing end stage renal disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) CZ (Completed) DE (Completed) BE (Completed) SE (Completed) DK (Completed) IT (Completed) GB (Completed) NL (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
